Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1951 1
1957 3
1959 1
1962 1
1964 2
1967 2
1968 2
1969 1
1970 1
1972 3
1973 3
1974 1
1975 17
1976 15
1977 8
1978 21
1979 12
1980 22
1981 26
1982 16
1983 28
1984 42
1985 32
1986 29
1987 44
1988 40
1989 69
1990 39
1991 41
1992 42
1993 39
1994 49
1995 38
1996 53
1997 55
1998 60
1999 80
2000 63
2001 79
2002 65
2003 83
2004 59
2005 71
2006 85
2007 81
2008 72
2009 93
2010 84
2011 105
2012 91
2013 90
2014 105
2015 104
2016 86
2017 87
2018 102
2019 91
2020 112
2021 114
2022 118
2023 124
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

2,913 results

Results by year

Filters applied: . Clear all
Page 1
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D, Hughes M, Kumar S, Peng X, Oyasiji T, Jabbour H, Khoury T. El Zein D, et al. Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26. Clin Breast Cancer. 2017. PMID: 28529029 Free PMC article. Review.
BACKGROUND: We aimed to describe our experience with metaplastic breast carcinoma (MBC), evaluate its clinical outcome compared with triple-negative breast cancer (TNBC), and provide a through and comprehensive review of the literature to date. ...RESULTS: There wer …
BACKGROUND: We aimed to describe our experience with metaplastic breast carcinoma (MBC), evaluate its clinical outcome compare …
Spindle Cell Metaplastic Breast Carcinoma.
Sanmugasiva V, Hamid MTR, Fadzli F, Ab Mumin N, Rahmat K. Sanmugasiva V, et al. Curr Med Imaging. 2022;18(6):684-688. doi: 10.2174/1573405617666211004114041. Curr Med Imaging. 2022. PMID: 34607549

INTRODUCTION: Metaplastic breast carcinoma is an uncommon malignancy that constitutes < 5% of all breast cancers. There are 5 subtypes which are spindle cell, squamous cell, carcinosarcoma, matrix-producing and metaplastic with osteoclastic giant cells. Sp

INTRODUCTION: Metaplastic breast carcinoma is an uncommon malignancy that constitutes < 5% of all breast cancers. There are

TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748 Free article.
Although GATA3 is the most widely used tumor marker at present to determine the breast origin, which has been shown to be an excellent marker for ER-positive and low-grade breast cancer, but it does not work well for TNBC with sensitivity as low as <20% in metaplastic b …
Although GATA3 is the most widely used tumor marker at present to determine the breast origin, which has been shown to be an excellent marke …
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. Yoon EC, et al. Hum Pathol. 2022 Jul;125:97-107. doi: 10.1016/j.humpath.2022.04.006. Epub 2022 Apr 9. Hum Pathol. 2022. PMID: 35413381
TRPS1 was highly expressed in 100% of triple-negative primary and metastatic invasive lobular carcinomas, 99% of triple-negative primary and metastatic invasive breast carcinoma of no special type (IBC-NST), and 95% of metaplastic breast carcinomas. In …
TRPS1 was highly expressed in 100% of triple-negative primary and metastatic invasive lobular carcinomas, 99% of triple-negative prim …
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
González-Martínez S, Pérez-Mies B, Pizarro D, Caniego-Casas T, Cortés J, Palacios J. González-Martínez S, et al. Int J Mol Sci. 2021 Jul 9;22(14):7398. doi: 10.3390/ijms22147398. Int J Mol Sci. 2021. PMID: 34299016 Free PMC article. Review.
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with poor prognosis. ...
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with
Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
Salemis NS. Salemis NS. Breast Dis. 2018;37(3):169-175. doi: 10.3233/BD-170313. Breast Dis. 2018. PMID: 29504519 Review.
Metaplastic carcinoma of the breast with mesenchymal differentiation (MCMD), previously known as carcinosarcoma, is a very rare and aggressive tumor that has been recently classified as a subtype of metaplastic breast carcinoma. ...Metaplastic b
Metaplastic carcinoma of the breast with mesenchymal differentiation (MCMD), previously known as carcinosarcoma, is a very rar
Molecular alterations in metaplastic breast carcinoma.
Cooper CL, Karim RZ, Selinger C, Carmalt H, Lee CS, O'Toole SA. Cooper CL, et al. J Clin Pathol. 2013 Jun;66(6):522-8. doi: 10.1136/jclinpath-2012-201086. Epub 2013 Jan 31. J Clin Pathol. 2013. PMID: 23372178 Review.
Metaplastic carcinoma of the breast is a rare and heterogeneous subtype of breast carcinoma with a generally poor outcome, and few therapeutic options once disease recurs or progresses. Metaplastic carcinomas of the breast are usually of a large
Metaplastic carcinoma of the breast is a rare and heterogeneous subtype of breast carcinoma with a generally poor outco
Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.
Victoor J, Bourgain C, Vander Borght S, Vanden Bempt I, De Rop C, Floris G. Victoor J, et al. Diagn Pathol. 2020 Mar 3;15(1):20. doi: 10.1186/s13000-020-00943-x. Diagn Pathol. 2020. PMID: 32127014 Free PMC article. Review.
BACKGROUND: We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as a subtype of metaplas
BACKGROUND: We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This excee …
Metaplastic carcinoma of the breast: Treatment, results and prognostic factors based on international literature.
Sanguinetti A, Lucchini R, Santoprete S, Farabi R, Fioriti L, Bistoni G, Triola R, Avenia N. Sanguinetti A, et al. Ann Ital Chir. 2014 Mar-Apr;85(2):109-13. Ann Ital Chir. 2014. PMID: 24195912 Review.
Metaplastic carcinoma of the breast (MCB) is a rare form of cancer containing mixture of epithelial and mesenchymal elements in variable combinations. ...
Metaplastic carcinoma of the breast (MCB) is a rare form of cancer containing mixture of epithelial and mesenchymal elements i
Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute.
Hasbay B, Bolat FA, Aytaç HÖ, Aslan H, Purbager A. Hasbay B, et al. Turk Patoloji Derg. 2020;36(1):23-30. doi: 10.5146/tjpath.2019.01472. Turk Patoloji Derg. 2020. PMID: 31769499 Free PMC article.
Pathological evaluation of cases showed that 14 were pure epithelial (IC-NST + squamous cell carcinoma) and 24 were metaplastic carcinomas with mesenchymal differentiation. ...Our findings are consistent with the literature. CONCLUSION: Metaplastic bre …
Pathological evaluation of cases showed that 14 were pure epithelial (IC-NST + squamous cell carcinoma) and 24 were metaplastic
2,913 results